Twelve French towns see bans on tap-water drinking over hormone-disrupting PFAS chemicals, as Australia introduces PFAS ban.

Xero’s $2.5B Melio buy aims for US growth, but at the cost of margins. Will it pay off, or repeat past acquisition mistakes? Key risks and analysis.

Labor records historic primary-vote lows but may still form government in diverse coalition with Greens and Independents.

I (GrowthGauge) first bought LaserBond (ASX: LBL) on 5 April 2019 at $0.425. The price soon doubled, then sank to $0.28 in the COVID crash. It climbed to almost $1.00 in 2021 and has drifted since.

Yesterday afternoon, just before 5 pm, traffic enforcement company Acusensus (ASX: ACE) announced that a competitor in Australia, Redflex Pty Ltd, had commenced legal proceedings against both ...

In one of those mildly devastating hits I didn’t see coming, the CEO and Chairman of Polynovo (ASX: PNV) had a falling out recently. Unfortunately for me, the company did not acknowledge the problem ...

On Tuesday, hotel software provider SiteMinder (ASX: SDR) reported its results. Revenue was up 26% to $190.7 million and the loss roughly halved to $28.5m. The company burnt about $10m in cash but ...

The Xero share price gained around 8% after its FY 2024 results, which showed unambiguous improvement in key operating metrics.

The Camplify share price failed to respond to the FY 2023 Camplify results, despite very strong revenue growth and positive free cash flow.

Pathology workflow software stock Beamtree (ASX: BMT) saw its share price fall from almost 20x revenue per share to around 3x.

Despite a stellar track record of growing earnings, cashflow, and dividends, this tailwind stock hasn't yet joined the S&P ASX 200.

DGL Group (ASX: DGL) shares have dropped a long way from the highs, and arguably DGL Group shares are now quite cheap.